Kaposi sarcoma (KS) is a vascular tumor first described by Moritz Kaposi (Kohn) in 1872 and recently linked to human herpesvirus 8. All forms of KS share the same pathologic features, including atypical spindle cells and slitlike vascular spaces. The exact origin of the neoplastic endothelial cells (vascular vs lymphatic) has recently been debated.
We sought to further investigate the origin of neoplastic cells in KS.
D2-40, a novel monoclonal antibody to a sialoglycoprotein that reacts with a fixation-resistant epitope in lymphatic endothelium, was used to investigate possible lymphatic origin of neoplastic cells in KS.
We report 5 cases of tumor-stage KS that showed positive staining with lymphatic marker D2-40.
Small study size is a limitation.
The origin of neoplastic cells in KS may be lymphatic or mixed lymphatic and vascular. Further studies are needed to elucidate the exact origin of neoplastic cells in KS.Le texte complet de cet article est disponible en PDF.
Key words : D2-40, Kaposi sarcoma, lymphatic, tumor stage, vascular
Abbreviations used : HHV, KS, mAb
| Gary Goldenberg, MD, is now with the Department of Dermatology, Mount Sinai School of Medicine, New York, New York.
| Funding sources: None.
| Conflicts of interest: None declared.
| Reprints not available from the authors.